Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Synthesis of Human Bone Morphogenetic Protein-2 (hBMP-2) in E. coli Periplasmic Space: Its Characterization and Preclinical Testing

Full text
Author(s):
Oliveira, Joao E. [1] ; Suzuki, Miriam F. [1] ; Damiani, Renata [2] ; Lima, Eliana R. [2] ; Amaral, Kleicy C. [1] ; Santos, Anderson M. S. [3] ; Magalhaes, Geraldo S. [4] ; Faverani, Leonardo P. [3] ; Pereira, Luis A. V. D. [5] ; Bartolini, Paolo [1]
Total Authors: 10
Affiliation:
[1] IPEN CNEN, Inst Pesquisas Energet & Nucl, Ave Prof Lineu Prestes 2242, BR-05508000 Sao Paulo, SP - Brazil
[2] Biosintesis P&D, BR-05508000 Sao Paulo, SP - Brazil
[3] UNESP, Sao Paulo State Univ, Sch Dent, Dept Diag & Surg, BR-16015050 Aracatuba, SP - Brazil
[4] Inst Butantan, Immunopathol Lab, BR-05503900 Sao Paulo, SP - Brazil
[5] Univ Estadual Campinas, Dept Biochem & Tissue Biol, Inst Biol, State Univ Campinas, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: CELLS; v. 10, n. 12 DEC 2021.
Web of Science Citations: 0
Abstract

Human BMP-2, a homodimeric protein that belongs to the TGF- beta family, is a recognized osteoinductor due to its capacity of inducing bone regeneration and ectopic bone formation. The administration of its recombinant form is an alternative to autologous bone grafting. A variety of E. coli-derived hBMP-2 has been synthesized through refolding of cytoplasmic inclusion bodies. The present work reports the synthesis, purification, and characterization of periplasmic hBMP-2, obtained directly in its correctly folded and authentic form, i.e., without the initial methionine typical of the cytoplasmic product that can induce undesired immunoreactivity. A bacterial expression vector was constructed including the DsbA signal peptide and the cDNA of hBMP-2. The periplasmic fluid was extracted by osmotic shock and analyzed via SDS-PAGE, Western blotting, and reversed-phase high-performance liquid chromatography (RP-HPLC). The purification was carried out by heparin affinity chromatography, followed by high-performance size-exclusion chromatography (HPSEC). HPSEC was used for qualitative and quantitative analysis of the final product, which showed >95% purity. The classical in vitro bioassay based on the induction of alkaline phosphatase activity in myoblastic murine C2C12 cells and the in vivo bioassay consisting of treating calvarial critical-size defects in rats confirmed its bioactivity, which matched the analogous literature data for hBMP-2. (AU)

FAPESP's process: 15/15446-0 - Expression, purification and characterization of bone morphogenetic protein (BMP-2) for application in composites biomaterials with poly(E-caprolactone)
Grantee:Paolo Bartolini
Support type: Research Grants - Innovative Research in Small Business - PIPE
FAPESP's process: 16/24724-6 - Expression, purification and characterization of bone morphogenetic protein (BMP-2) for application in composites biomaterials with poly(E-caprolactone)
Grantee:Paolo Bartolini
Support type: Research Grants - Innovative Research in Small Business - PIPE